Logo image of CNVS

CINEVERSE CORP (CNVS) Stock Fundamental Analysis

NASDAQ:CNVS - US1724063086 - Common Stock

4.89 USD
-0.29 (-5.6%)
Last: 8/29/2025, 8:14:04 PM
4.37 USD
-0.52 (-10.63%)
Pre-Market: 9/2/2025, 4:01:38 AM
Fundamental Rating

4

Overall CNVS gets a fundamental rating of 4 out of 10. We evaluated CNVS against 79 industry peers in the Entertainment industry. CNVS has only an average score on both its financial health and profitability. CNVS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CNVS was profitable.
CNVS had a positive operating cash flow in the past year.
In multiple years CNVS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CNVS reported negative operating cash flow in multiple years.
CNVS Yearly Net Income VS EBIT VS OCF VS FCFCNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

CNVS has a better Return On Assets (4.49%) than 79.75% of its industry peers.
CNVS's Return On Equity of 7.45% is fine compared to the rest of the industry. CNVS outperforms 75.95% of its industry peers.
The Return On Invested Capital of CNVS (13.82%) is better than 89.87% of its industry peers.
Industry RankSector Rank
ROA 4.49%
ROE 7.45%
ROIC 13.82%
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
CNVS Yearly ROA, ROE, ROICCNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

The Profit Margin of CNVS (3.44%) is better than 69.62% of its industry peers.
CNVS's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 8.73%, CNVS is doing good in the industry, outperforming 70.89% of the companies in the same industry.
In the last couple of years the Operating Margin of CNVS has grown nicely.
CNVS has a Gross Margin of 51.23%. This is comparable to the rest of the industry: CNVS outperforms 59.49% of its industry peers.
In the last couple of years the Gross Margin of CNVS has declined.
Industry RankSector Rank
OM 8.73%
PM (TTM) 3.44%
GM 51.23%
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
CNVS Yearly Profit, Operating, Gross MarginsCNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNVS is creating some value.
Compared to 1 year ago, CNVS has more shares outstanding
The number of shares outstanding for CNVS has been increased compared to 5 years ago.
There is no outstanding debt for CNVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CNVS Yearly Shares OutstandingCNVS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CNVS Yearly Total Debt VS Total AssetsCNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -7.52, we must say that CNVS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CNVS (-7.52) is worse than 81.01% of its industry peers.
CNVS has a debt to FCF ratio of 0.90. This is a very positive value and a sign of high solvency as it would only need 0.90 years to pay back of all of its debts.
CNVS has a better Debt to FCF ratio (0.90) than 83.54% of its industry peers.
CNVS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
CNVS's Debt to Equity ratio of 0.10 is in line compared to the rest of the industry. CNVS outperforms 59.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.9
Altman-Z -7.52
ROIC/WACC1.47
WACC9.4%
CNVS Yearly LT Debt VS Equity VS FCFCNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.99 indicates that CNVS may have some problems paying its short term obligations.
CNVS has a Current ratio (0.99) which is in line with its industry peers.
CNVS has a Quick Ratio of 0.99. This is a bad value and indicates that CNVS is not financially healthy enough and could expect problems in meeting its short term obligations.
CNVS has a Quick ratio of 0.99. This is comparable to the rest of the industry: CNVS outperforms 49.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
CNVS Yearly Current Assets VS Current LiabilitesCNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 115.38% over the past year.
The Earnings Per Share has been decreasing by -3.06% on average over the past years.
The Revenue has grown by 77.08% in the past year. This is a very strong growth!
CNVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.75% yearly.
EPS 1Y (TTM)115.38%
EPS 3Y-3.06%
EPS 5YN/A
EPS Q2Q%-5%
Revenue 1Y (TTM)77.08%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%21.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y47.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNVS Yearly Revenue VS EstimatesCNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CNVS Yearly EPS VS EstimatesCNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80 -100

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CNVS is valuated quite expensively with a Price/Earnings ratio of 61.12.
Compared to the rest of the industry, the Price/Earnings ratio of CNVS indicates a somewhat cheap valuation: CNVS is cheaper than 70.89% of the companies listed in the same industry.
CNVS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.13.
With a Price/Forward Earnings ratio of 36.88, CNVS can be considered very expensive at the moment.
68.35% of the companies in the same industry are more expensive than CNVS, based on the Price/Forward Earnings ratio.
CNVS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 61.12
Fwd PE 36.88
CNVS Price Earnings VS Forward Price EarningsCNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNVS is valued cheaper than 84.81% of the companies in the same industry.
83.54% of the companies in the same industry are more expensive than CNVS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.11
EV/EBITDA 8.3
CNVS Per share dataCNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

CNVS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.29
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CINEVERSE CORP

NASDAQ:CNVS (8/29/2025, 8:14:04 PM)

Premarket: 4.37 -0.52 (-10.63%)

4.89

-0.29 (-5.6%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-12 2025-11-12
Inst Owners15.81%
Inst Owner Change33.84%
Ins Owners13.53%
Ins Owner Change1.88%
Market Cap93.30M
Analysts82.5
Price Target8.67 (77.3%)
Short Float %2.85%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.53%
Min EPS beat(2)-157.35%
Max EPS beat(2)152.29%
EPS beat(4)3
Avg EPS beat(4)7.67%
Min EPS beat(4)-157.35%
Max EPS beat(4)152.29%
EPS beat(8)5
Avg EPS beat(8)11.57%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.03%
Min Revenue beat(2)6.87%
Max Revenue beat(2)7.19%
Revenue beat(4)4
Avg Revenue beat(4)10.02%
Min Revenue beat(4)6.87%
Max Revenue beat(4)16.23%
Revenue beat(8)4
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)3%
Revenue beat(16)9
Avg Revenue beat(16)6.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)100%
EPS NQ rev (3m)300%
EPS NY rev (1m)262.5%
EPS NY rev (3m)244.44%
Revenue NQ rev (1m)-2.09%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)3.43%
Revenue NY rev (3m)3.85%
Valuation
Industry RankSector Rank
PE 61.12
Fwd PE 36.88
P/S 1.16
P/FCF 23.11
P/OCF 20.28
P/B 2.52
P/tB 7.89
EV/EBITDA 8.3
EPS(TTM)0.08
EY1.64%
EPS(NY)0.13
Fwd EY2.71%
FCF(TTM)0.21
FCFY4.33%
OCF(TTM)0.24
OCFY4.93%
SpS4.2
BVpS1.94
TBVpS0.62
PEG (NY)1.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.49%
ROE 7.45%
ROCE 19.23%
ROIC 13.82%
ROICexc 14.54%
ROICexgc 43.24%
OM 8.73%
PM (TTM) 3.44%
GM 51.23%
FCFM 5.04%
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y117.54%
ROICexc growth 5YN/A
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
F-Score7
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.9
Debt/EBITDA 0.33
Cap/Depr 14.09%
Cap/Sales 0.7%
Interest Coverage 8.81
Cash Conversion 41.84%
Profit Quality 146.3%
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z -7.52
F-Score7
WACC9.4%
ROIC/WACC1.47
Cap/Depr(3y)30.78%
Cap/Depr(5y)28.81%
Cap/Sales(3y)1.85%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.38%
EPS 3Y-3.06%
EPS 5YN/A
EPS Q2Q%-5%
EPS Next Y47.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)77.08%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%21.83%
Revenue Next Year0.98%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y504.16%
EBIT growth 3Y93.13%
EBIT growth 5YN/A
EBIT Next Year94.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y132.94%
FCF growth 3Y56.46%
FCF growth 5Y20.06%
OCF growth 1Y142.37%
OCF growth 3Y52.8%
OCF growth 5Y17.54%